On Feb. 5, PolyMedica
- Sales were up by 34.3 %, backed by stellar growth of 157% in pharma revenues and 10% growth in diabetes revenues.
- Operating margins have been affected by an increase in cost of sales by 57%, keeping the sales growth from falling to the bottom line.
- The board has declared a quarterly dividend of $0.15 per share, payable by Feb. 15.
- A buyback of shares and acquisitions during 2006-2007 resulted in an increase in long-term debt.
(Figures in millions, except per-share data)
Income Statement Highlights
Q3 2007 |
Q3 2006 |
Change |
|
---|---|---|---|
Sales |
$177.2 |
$131.9 |
34.3% |
Net Profit |
$9.8 |
$9.6 |
2.3% |
EPS |
$0.43 |
$0.40 |
7.5% |
Diluted Shares |
23.2 |
24.3 |
(4.6%) |
Get back to basics with a look at the income statement.
Margin Checkup
Q3 2007 |
Q3 2006 |
Change* |
|
---|---|---|---|
Gross Margin |
44.2% |
52.3% |
(8.1) |
Operating Margin |
9.7% |
12.6% |
(2.9) |
Net Margin |
5.6% |
7.3% |
(1.7) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q3 2007 |
Q3 2006 |
Change |
---|---|---|---|
Cash + ST Investments |
$1.3 |
$6.1 |
(78.1%) |
Accounts Receivable |
$104.6 |
$92.7 |
12.9% |
Inventory |
$44.6 |
$40.0 |
11.6% |
Liabilities |
Q3 2007 |
Q3 2006 |
Change |
---|---|---|---|
Accounts Payable* |
$61.2 |
$30.7 |
99.4% |
Long-Term Debt** |
$237.6 |
$167.5 |
41.9% |
**Long-term debt includes capital lease and other obligations and credit facility.
Learn the ways of the balance sheet.
Cash Flow Highlights
YTD 2007 |
YTD 2006 |
Change |
|
---|---|---|---|
Cash From Ops. |
$42.3 |
$11.7 |
261.1% |
Capital Expenditures |
$8.1 |
$7.9 |
2.5% |
Free Cash Flow |
$34.2 |
$3.8 |
805.0% |
Find out why Fools always follow the money.
Related Companies:
-
Pharmion
(NASDAQ:PHRM) -
Cubist Pharmaceuticals
(NASDAQ:CBST) -
Myriad Genetics
(NASDAQ:MYGN) -
Sciele Pharma
(NASDAQ:SCRX)
Related Foolishness:
Myriad Genetics is a Rule Breakers recommendation. To see what other movers and shakers make up the Rule Breakers portfolio, check out David Gardner's service free for 30 days.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.